Sie befinden sich hier: Startseite » Mitglieder » Verordnungen » Arzneimittel A-Z

Arzneimittel A bis Z

Auf dieser Seite erhalten Sie Hinweise zur Verordnungsfähigkeit und Wirtschaftlichkeit von

Arzneimitteln. Hier finden Sie ein Archiv an Artikeln der KV Sachsen, alphabetisch

nach Wirkstoffnamen oder Substanzklasse sortiert.

Weiterhin finden Sie hier zukünftig die Hinweise der gemeinsamen Arbeitsgruppe Arzneimittel der KV Sachsen und der sächsischen Krankenkassen zu den Wirtschaftlichkeitszielen der Arzneimittelvereinbarung. Ergänzend werden Sie „Rote-Hand-Briefe“ und „Wirkstoff

AKTUELL“ der Kassenärztlichen Bundesvereinigung der letzten 3 Jahre finden.

 

 

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   X   Z  

  Quelle  Stand 

A

Abilify® (Aripiprazol) (171 KB) Wirkstoff AKTUELL 11/2009
Abraxane® (Paclitaxel) (236 KB) Rote-Hand-Brief 01/2014
Aceclofenac (Beofenac®) (224 KB) Rote-Hand-Brief 10/2014
Adempas® (Riociguat) (186 KB) Rote-Hand-Brief 07/2016
Adenuric® (Febuxostat) (126 KB) Wirkstoff AKTUELL 08/2014
Aggrenox® (Dipyridamol/ASS) (38 KB) KVSM 04/2014
Agomelatin (Valdoxan®) (164 KB) Wirkstoff AKTUELL 04/2010
AH3® (Hydroxyzin) (394 KB) Rote-Hand-Brief 04/2015
Aktinische Keratose (360 KB) Wirkstoff AKTUELL 05/2017
Alirocumab (Praluent®) (47 KB) KVSonline 10/2016
Aliskiren (Rasilez®) (45 KB) KVSM 09/2010
Ambene® (Phenylbutazon/Lidocain) (38 KB) KVSonline 08/2017
Ambrisentan (Volibris®) (0,9 MB) Rote-Hand-Brief 06/2012
Ambroxol (Mucosolvan®) (87 KB) Rote-Hand-Brief 08/2013
Anagrelid (Xagrid®) (505 KB) Rote-Hand-Brief 01/2013
Analgetika bei degenerativen Gelenkerkrankungen (113 KB) Wirkstoff AKTUELL 05/2014
Anemet® (Dolasetron) (67 KB) Rote-Hand-Brief 02/2011
Angiox® (Bivalirudin) (172 KB) Rote-Hand-Brief 01/2013
Anoro® (Umeclidinium/Vilanterol) (301 KB) Wirkstoff AKTUELL 08/2015
Antibiotika, Patienteninformation (178 KB) KBV 04/2012
Antibiotikatherapie bei Harnwegsinfektionen (358 KB) Wirkstoff AKTUELL 09/2017
Antibiotikatherapie bei Harnwegsinfektionen (1,0 MB) Wirkstoff AKTUELL 03/2012
Antibiotikatherapie bei Infektionen der oberen Atemwege (564 KB) Wirkstoff AKTUELL 12/2011
Antibiotikatherapie bei Infektionen der unteren Atemwege (436 KB) Wirkstoff AKTUELL 02/2017
Antibiotikatherapie in Sachsen (35 KB) KVSM 04/2012
Antibiotikatherapie, Optimierung (293 KB) KVSM 05/2011
Antidiabetika, Verordnungseinschränkungen (44 KB) KVSM 09/2010
Anti-D-Immunglobulin (Rhesonativ®) (4,7 MB) Rote-Hand-Brief 10/2013
Antihistaminika, Regressprophylaxe (73 KB) KVSonline 05/2013
Antikoagulantien, oral (70 KB) KVSM 10/2011
Antikoagulantien (49 KB) KVSM 02/2013
Antiphlogistika/Antirheumatika (49 KB) KVSM 02/2013
Apidra® (Insulinglulisin) (74 KB) Rote-Hand-Brief 09/2011
Apixaban (Eliquis®) (108 KB) Rote-Hand-Brief 09/2013
Apremilast (Otezla®) (346 KB) Rote-Hand-Brief 11/2016
Apremilast (Otezla®) (308 KB) Wirkstoff AKTUELL 09/2016
Arcoxia® (Etoricoxib) (175 KB) Rote-Hand-Brief 07/2016
Aripiprazol (Abilify®) (171 KB) Wirkstoff AKTUELL 11/2009
Arixtra® (Fondaparinux) (262 KB) Wirkstoff AKTUELL 06/2010
Arzerra® (Ofatumumab) (270 KB) Rote-Hand-Brief 07/2014
Arzerra® (Ofatumumab) (1,0 MB) Rote-Hand-Brief 12/2013
Arzneimittelmarktneuordnungsgesetz (AMNOG) (40 KB) KVSM 02/2011
Arzneimittelrichtlinie FAQ (153 KB) KBV 11/2018
Arzneimittelzuzahlungen (34 KB) KVSM 10/2010
Asenapin (Sycrest®) (866 KB) Wirkstoff AKTUELL 11/2013
Atarax® (Hydroxyzin) (394 KB) Rote-Hand-Brief 04/2015
Atezolizumab (Tecentriq®) (364 KB) Rote-Hand-Brief 07/2018
Atomoxetin (Strattera®) (571 KB) Rote-Hand-Brief 12/2011
Atorvastatin Basics® (1,4 MB) Rote-Hand-Brief 04/2012
Aut-idem (67 KB) KVSonline 01/2015
Aut-idem-Kreuz (40 KB) KVSM 12/2013
Aut-idem-Kreuz (33 KB) KVSM 09/2013
Avastin® (Bevacizumab) (1,7 MB) Rote-Hand-Brief 05/2013
Avastin® (Bevacizumab) (1,8 MB) Rote-Hand-Brief 11/2010
Avastin® (Bevacizumab) (799 KB) Rote-Hand-Brief 05/2010
Azilect® (Rasagilin) (550 KB) Wirkstoff AKTUELL 07/2013
Azithromycin (Ultreon®, Zithromax®) (202 KB) Rote-Hand-Brief 05/2018

nach oben

B

Basiliximab (Simulect®) (334 KB) Rote-Hand-Brief 09/2014
Becaplermin (Regranex®) (60 KB) Rote-Hand-Brief 03/2010
Beclometason/Formoterol/Glycopyrronium (Trimbow®) (276 KB) Wirkstoff AKTUELL 08/2017
Belimumab (Benlysta®) (290 KB) Rote-Hand-Brief 03/2012
Belimumab (Benlysta®) (784 KB) Rote-Hand-Brief 03/2019
Bendamustin (Levact®) (291 KB) Rote-Hand-Brief 08/2017
Benlysta® (Belimumab) (290 KB) Rote-Hand-Brief 03/2012
Benlysta® (Belimumab) (784 KB) Rote-Hand-Brief 03/2019
Beofenac® (Aceclofenac) (224 KB) Rote-Hand-Brief 10/2014
Berodual® (Ipratropium/Fenoterol) (26 KB) KVSM 06/2013
Beta-Interferone (119 KB) Rote-Hand-Brief 08/2014
Betmiga® (Mirabegron) (259 KB) Rote-Hand-Brief 09/2015
Betmiga® (Mirabegron) (300 KB) Wirkstoff AKTUELL 11/2017
Betäubungsmittel, Verordnungshinweise (75 KB) KVSM 12/2010
Bevacizumab (Avastin®) (799 KB) Rote-Hand-Brief 05/2010
Bevacizumab (Avastin®) (1,8 MB) Rote-Hand-Brief 11/2010
Bevacizumab (Avastin®) (1,7 MB) Rote-Hand-Brief 05/2013
Biologische Basistherapeutika bei rheumatoider Arthritis (313 KB) Wirkstoff AKTUELL 08/2010
Biosimilars (880 KB) Wirkstoff AKTUELL 07/2017
Bivalirudin (Angiox®) (172 KB) Rote-Hand-Brief 01/2013
Blinatumomab (Blincyto®) (149 KB) Rote-Hand-Brief 10/2016
Blincyto® (Blinatumomab) (149 KB) Rote-Hand-Brief 10/2016
Blutzuckerteststreifen (156 KB) KVSM 12/2010
Boceprevir (Victrelis®) (117 KB) Rote-Hand-Brief 02/2012
Bortezomib (Velcade®) (118 KB) Rote-Hand-Brief 01/2012
Bosulif® (Bosutinib) (141 KB) Rote-Hand-Brief 04/2016
Brilique® (Ticagrelor) (36 KB) KVSM 09/2012
Brivudin (Zostex®) (440 KB) Rote-Hand-Brief 08/2012
Bromocriptin (3,4 MB) Rote-Hand-Brief 12/2014
BtM-Rezepte, Gemeinschaftspraxis (28 KB) KVSM 07-08/2010
Buccolam® (Midazolam) (113 KB) Rote-Hand-Brief 11/2017
Buccolam® (Midazolam) (103 KB) Rote-Hand-Brief 01/2018

nach oben

C

Caelyx® (Doxorubicin) (109 KB) Rote-Hand-Brief 11/2011
Caelyx® (Doxorubicin) (148 KB) Rote-Hand-Brief 10/2012
Caelyx® (Doxorubicin) (109 KB) Rote-Hand-Brief 09/2011
Caelyx® (Doxorubicin) (102 KB) Rote-Hand-Brief 08/2011
Calcitonin (300 KB) Rote-Hand-Brief 08/2012
Capecitabin (Xeloda®) (82 KB) Rote-Hand-Brief 12/2013
Capsaicin (Qutenza®) (249 KB) Wirkstoff AKTUELL 08/2010
Carbimazol (1,5 MB) Rote-Hand-Brief 02/2019
Carbomedac® (Carboplatin) (35 KB) Rote-Hand-Brief 04/2012
Carboplatin onkovis® (Carboplatin) (86 KB) Rote-Hand-Brief 04/2012
Cardioxane® (Dexrazoxan) (1,4 MB) Rote-Hand-Brief 07/2010
Cardioxane® (Dexrazoxan) (243 KB) Rote-Hand-Brief 07/2011
Cefepim (Maxipime®) (85 KB) Rote-Hand-Brief 06/2018
CellCept® (Mycophenolat) (55 KB) Rote-Hand-Brief 12/2014
Cellcept® (Mycophenolatmofetil) (367 KB) Rote-Hand-Brief 11/2015
Ceplene® (Histamindihydrochlorid) (283 KB) Rote-Hand-Brief 12/2011
Cetuximab (Erbitux®) (405 KB) Rote-Hand-Brief 01/2014
Chinolone (1,5 MB) Rote-Hand-Brief 04/2019
Cidofovir (Vistide®) (122 KB) Rote-Hand-Brief 01/2011
Cidofovir (Vistide®) (93 KB) Rote-Hand-Brief 02/2013
Cilest® (Norgestimat) (337 KB) Rote-Hand-Brief 06/2013
Cilostazol (Pletal®) (35 KB) KVSM 02/2012
Cilostazol (Pletal®) (3,0 MB) Rote-Hand-Brief 05/2013
Cilostazol (Pletal®) (43 KB) KVSonline 05/2015
Cinacalcet (Mimpara®) (222 KB) Rote-Hand-Brief 03/2013
Cipralex® (Escitalopram) (137 KB) Rote-Hand-Brief 12/2011
Cipramil® (Citalopram) (130 KB) Rote-Hand-Brief 10/2011
Citalopram (Cipramil®) (130 KB) Rote-Hand-Brief 10/2011
Cladribin (Leustatin®, Litak®) (72 KB) Rote-Hand-Brief 12/2017
Clopidogrel (128 KB) Rote-Hand-Brief 08/2013
Cobicistat (Genvoya®, Stribild®,Tybost®) (789 KB) Rote-Hand-Brief 03/2019
Cobimetinib (Cotellic®) (105 KB) Rote-Hand-Brief 04/2017
Cosopt® (Dorzolamid/Timolol) (163 KB) Rote-Hand-Brief 11/2013
Cotellic® (Cobimetinib) (105 KB) Rote-Hand-Brief 04/2017
Crizotinib (Xalkori®) (137 KB) Rote-Hand-Brief 10/2015
Cubicin® (Daptomycin) (1,8 MB) Rote-Hand-Brief 01/2011
Cyproteronacetat/Ethinylestradiol (292 KB) Rote-Hand-Brief 06/2013
Cytarabin (DepoCyte®) (175 KB) Rote-Hand-Brief 07/2013
Cytarabin (DepoCyte®) (218 KB) Rote-Hand-Brief 08/2012

nach oben

D

Dabigatranetexilat (Pradaxa®) (172 KB) Wirkstoff AKTUELL 10/2009
Dabigatranetexilat (Pradaxa®) (486 KB) Rote-Hand-Brief 10/2011
Dabigatranetexilat (Pradaxa®) (108 KB) Rote-Hand-Brief 09/2013
Dabigatranetexilat (Pradaxa®) (338 KB) Rote-Hand-Brief 01/2013
Dabigatranetexilat (Pradaxa®) (1,0 MB) Wirkstoff AKTUELL 01/2013
Daclatasvir (Daklinza®) (134 KB) Rote-Hand-Brief 05/2015
Daclizumab (Zinbryta®) (261 KB) Rote-Hand-Brief 03/2018
Daclizumab (Zinbryta®) (264 KB) Rote-Hand-Brief 11/2017
Daclizumab (Zinbryta®) (457 KB) Rote-Hand-Brief 07/2017
Daclizumab (Zinbryta®) (277 KB) Rote-Hand-Brief 08/2018
Daklinza® (Daclatasvir) (134 KB) Rote-Hand-Brief 05/2015
Daptomycin (Cubicin®) (1,8 MB) Rote-Hand-Brief 01/2011
Darunavir/Cobicistat (Prezista®, Symtuza®) (395 KB) Rote-Hand-Brief 06/2018
Dasatinib (Sprycel®) (141 KB) Rote-Hand-Brief 04/2016
Dasatinib (Sprycel®) (344 KB) Rote-Hand-Brief 08/2011
Daxas® (Roflumilast) (212 KB) Wirkstoff AKTUELL 06/2011
Denosumab (Prolia®) (403 KB) Rote-Hand-Brief 02/2013
Denosumab (Prolia®) (185 KB) Wirkstoff AKTUELL 01/2011
Denosumab (Prolia®) (262 KB) Rote-Hand-Brief 09/2014
Denosumab (Prolia®) (339 KB) Wirkstoff AKTUELL 10/2018
Denosumab (Xgeva®) (166 KB) Rote-Hand-Brief 07/2015
Denosumab (Xgeva®) (274 KB) Rote-Hand-Brief 09/2014
Denosumab (Xgeva®) (416 KB) Rote-Hand-Brief 09/2012
DepoCyte® (Cytarabin) (218 KB) Rote-Hand-Brief 08/2012
DepoCyte® (Cytarabin) (175 KB) Rote-Hand-Brief 07/2013
Dexamethason (Supertendin®) (248 KB) Rote-Hand-Brief 10/2011
Dexamethason (Supertendin®) (200 KB) Rote-Hand-Brief 11/2011
Dexrazoxan (Cardioxane®) (1,4 MB) Rote-Hand-Brief 07/2010
Dexrazoxan (Cardioxane®) (243 KB) Rote-Hand-Brief 07/2011
Dianeal® (Peritonealdialyse-Lösung) (41 KB) Rote-Hand-Brief 01/2011
Diclofenac (249 KB) Rote-Hand-Brief 07/2013
Dienogest/Ethinylestradiol (243 KB) Rote-Hand-Brief 12/2018
Dihydroergotamin (100 KB) Rote-Hand-Brief 01/2014
Dihydroergotoxin (100 KB) Rote-Hand-Brief 03/2014
Dimethylfumarat (Tecfidera®) (442 KB) Rote-Hand-Brief 11/2015
Dimethylfumarat (Tecfidera®) (89 KB) Rote-Hand-Brief 12/2014
Dipyridamol/ASS (Aggrenox®) (38 KB) KVSM 04/2014
Direkte orale Antikoagulanzien (NOAK) (337 KB) Wirkstoff AKTUELL 10/2017
Distraneurin® (Clomethiazol) (32 KB) KVSM 06/2011
Dolasetron (Anemet®) (67 KB) Rote-Hand-Brief 02/2011
Dolutegravir (Juluca®, Tivicay®, Triumeq®) (201 KB) Rote-Hand-Brief 06/2018
Domperidon (174 KB) Rote-Hand-Brief 08/2014
Doribax® (Doripenem) (132 KB) Rote-Hand-Brief 07/2012
Dorzolamid/Timolol (Cosopt®) (163 KB) Rote-Hand-Brief 11/2013
Doxorubicin (Caelyx®) (109 KB) Rote-Hand-Brief 11/2011
Doxorubicin (Caelyx®) (109 KB) Rote-Hand-Brief 09/2011
Doxorubicin (Caelyx®) (102 KB) Rote-Hand-Brief 08/2011
Doxorubicin (Caelyx®) (148 KB) Rote-Hand-Brief 10/2012
Dronedaron (Multaq®) (790 KB) Wirkstoff AKTUELL 09/2012
Dronedaron (Multaq®) (424 KB) Rote-Hand-Brief 06/2011
Dronedaron (Multaq®) (161 KB) Rote-Hand-Brief 01/2011
Drotrecogin alfa (Xigris®) (209 KB) Rote-Hand-Brief 10/2011
Durogesic® SMAT (Fentanyl) (338 KB) Rote-Hand-Brief 03/2013

nach oben

E

Edronax® (Reboxetin) (31 KB) KVSM 06/2011
Efient® (Prasugrel) (410 KB) Rote-Hand-Brief 12/2013
Efient® (Prasugrel) (126 KB) KVSM 12/2010
Eisenpräparate, i.v. Applikation (188 KB) Rote-Hand-Brief 10/2013
Elektrolyt-Infusionslösungen (135 KB) Rote-Hand-Brief 06/2018
Eligard® (Leuprorelin) (189 KB) Rote-Hand-Brief 12/2017
Eliquis® (Apixaban) (108 KB) Rote-Hand-Brief 09/2013
Elvanse® (Lisdexamfetamin) (306 KB) Wirkstoff AKTUELL 10/2015
Elvitegravir (Genvoya®, Stribild®,Tybost®) (789 KB) Rote-Hand-Brief 03/2019
Entyvio® (Vedolizumab) (379 KB) Wirkstoff AKTUELL 10/2016
Epoetin (82 KB) Rote-Hand-Brief 09/2017
Erbitux ® (Cetuximab) (405 KB) Rote-Hand-Brief 01/2014
Erivedge® (Vismodegib) (2,8 MB) Rote-Hand-Brief 07/2013
Erivedge® (Vismodegib) (49 KB) Rote-Hand-Brief 06/2016
Erkältungskrankheiten, Arzneimittel-Verordnungsausschluss (31 KB) KVSM 04/2012
Erlotinib (Tarceva®) (623 KB) Rote-Hand-Brief 01/2016
Escitalopram (Cipralex®) (137 KB) Rote-Hand-Brief 12/2011
Eslicarbazepinacetat (Zebinix®) (794 KB) Wirkstoff AKTUELL 11/2012
Esmya® (Ulipristalacetat) (142 KB) Rote-Hand-Brief 02/2018
Esmya® (Ulipristalacetat) (428 KB) Rote-Hand-Brief 07/2018
Ethinylestradiol/Cyproteronacetat (292 KB) Rote-Hand-Brief 06/2013
Ethinylestradiol/Dienogest (243 KB) Rote-Hand-Brief 12/2018
Etonorgestrel (ImplanonNXT®) (0,9 MB) Rote-Hand-Brief 06/2016
Etoricoxib (Arcoxia®) (175 KB) Rote-Hand-Brief 07/2016
Euthyrox® (Levothyroxin) (1,2 MB) Rote-Hand-Brief 04/2019
Evicel® (Fibrinkleber) (115 KB) Rote-Hand-Brief 12/2012
Evolocumab (Repatha®) (48 KB) KVSonline 08/2016
Exelon® (Rivastigmin) (74 KB) Wirkstoff AKTUELL 01/2010
Extraneal® (Peritonealdialyse-Lösung) (41 KB) Rote-Hand-Brief 01/2011
Exviera® (Dasabuvir) (344 KB) Rote-Hand-Brief 01/2016
Ezetimib (Ezetrol®, Inegy®) (29 KB) KVSM 07/2010
Ezetimib/Simvastatin (Inegy®, Goltor®) (329 KB) Wirkstoff AKTUELL 11/2015
Ezetrol® (Ezetimib) (29 KB) KVSM 07/2010
Fibrinkleber (Evicel®) (115 KB) Rote-Hand-Brief 12/2012

nach oben

F

Febuxostat (Adenuric®) (126 KB) Wirkstoff AKTUELL 08/2014
Fenoterol (Partusisten® intrapartal) (106 KB) Rote-Hand-Brief 10/2012
Fenoterol (Partusisten®) (819 KB) Rote-Hand-Brief 09/2013
Fenoterol/Ipratropium (Berodual®) (26 KB) KVSM 06/2013
Fentanyl (Durogesic® SMAT) (338 KB) Rote-Hand-Brief 03/2013
Fentanyl (3,3 MB) Rote-Hand-Brief 06/2014
Fentanyl®-Janssen (325 KB) Rote-Hand-Brief 03/2013
Filgrastim (Neupogen®) (313 KB) Rote-Hand-Brief 08/2013
Finasterid (1,6 MB) Rote-Hand-Brief 07/2018
Fingolimod (Gilenya®) (2,1 MB) Rote-Hand-Brief 04/2012
Fingolimod (Gilenya®) (522 KB) Rote-Hand-Brief 11/2013
Fingolimod (Gilenya®) (117 KB) Rote-Hand-Brief 01/2013
Fingolimod (Gilenya®) (658 KB) Rote-Hand-Brief 01/2012
Fingolimod (Gilenya®) (247 KB) Rote-Hand-Brief 01/2016
Fingolimod (Gilenya®) (177 KB) Rote-Hand-Brief 05/2015
Fingolimod (Gilenya®) (176 KB) Rote-Hand-Brief 11/2017
Fluenz® (Influenza-Lebendimpfstoff ) (57 KB) KVSM 03/2012
Flunitrazepam (77 KB) KVSonline 11/2011
Fluorchinolone (1,8 MB) Rote-Hand-Brief 10/2018
Fluorchinolone (1,5 MB) Rote-Hand-Brief 04/2019
Flupigil® (Flupirtin) (104 KB) Rote-Hand-Brief 07/2013
Flupirtin (104 KB) Rote-Hand-Brief 07/2013
Fondaparinux (Arixtra®) (262 KB) Wirkstoff AKTUELL 06/2010
Formoterol/Beclometason/Glycopyrronium (Trimbow®) (276 KB) Wirkstoff AKTUELL 08/2017
Forsteo® (Teriparatid) (315 KB) Wirkstoff AKTUELL 11/2018
Fumaderm® (417 KB) Rote-Hand-Brief 11/2015
Fumaderm® (679 KB) Rote-Hand-Brief 06/2013

nach oben

G

Gadolinium (140 KB) Rote-Hand-Brief 01/2018
Galantaminhydrobromid (Reminyl®) (133 KB) Rote-Hand-Brief 09/2015
G-CSF (444 KB) Rote-Hand-Brief 06/2018
Genvoya® (Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamid) (789 KB) Rote-Hand-Brief 03/2019
Gilenya® (Fingolimod) (522 KB) Rote-Hand-Brief 11/2013
Gilenya® (Fingolimod) (658 KB) Rote-Hand-Brief 01/2012
Gilenya® (Fingolimod) (117 KB) Rote-Hand-Brief 01/2013
Gilenya® (Fingolimod) (177 KB) Rote-Hand-Brief 05/2015
Gilenya® (Fingolimod) (176 KB) Rote-Hand-Brief 11/2017
Gilenya® (Fingolimod) (2,1 MB) Rote-Hand-Brief 04/2012
Gilenya® (Fingolimod) (247 KB) Rote-Hand-Brief 01/2016
Gliptine, Nutzenbewertung (69 KB) KVSonline 12/2013
Glitazone (31 KB) KVSM 06/2011
Glivec® (Imatinib) (141 KB) Rote-Hand-Brief 04/2016
Glucocorticoide, intraartikuläre Injektion (33 KB) KVSM 01/2013
Glucose-Infusionslösungen (135 KB) Rote-Hand-Brief 06/2018
Glycopyrronium (Seebri® Breezhaler®, Ultibro® Breezhaler®) (128 KB) Wirkstoff AKTUELL 03/2014
Glycopyrronium/Beclometason/Formoterol (Trimbow®) (276 KB) Wirkstoff AKTUELL 08/2017
Goltor® (Simvastatin/Ezetimib) (329 KB) Wirkstoff AKTUELL 11/2015
Granocyte® (Lenograstim) (243 KB) Rote-Hand-Brief 03/2014
Grippeimpfstoffausschreibung 2013/14 (26 KB) KVSM 06/2013
Guanfacin (Intuniv®) (326 KB) Wirkstoff AKTUELL 04/2016

nach oben

H

Haldol® (Haloperidol) (149 KB) Rote-Hand-Brief 12/2017
Harvoni® (Sofosbuvir, Ledipasvir) (134 KB) Rote-Hand-Brief 05/2015
HCT (707 KB) Rote-Hand-Brief 10/2018
Herceptin® (Trastuzumab) (371 KB) Rote-Hand-Brief 04/2014
Herceptin® (Trastuzumab) (102 KB) Rote-Hand-Brief 03/2017
HES (Redibag®) (116 KB) Rote-Hand-Brief 07/2013
HES (434 KB) Rote-Hand-Brief 11/2013
Hexaminolevulinat (Hexvix®) (648 KB) Rote-Hand-Brief 12/2011
Hexvix® (Hexaminolevulinat) (648 KB) Rote-Hand-Brief 12/2011
Histamindihydrochlorid (Ceplene®) (283 KB) Rote-Hand-Brief 12/2011
Hörsturztherapie (31 KB) KVSM 03/2011
Hydroxyzin (Atarax®, AH3®) (394 KB) Rote-Hand-Brief 04/2015

nach oben

I

humanes Immunglobulin (Vivaglobin®) (352 KB) Rote-Hand-Brief 03/2011
Ibrutinib (Imbruvica®) (169 KB) Rote-Hand-Brief 07/2017
Ibuprofen (Pedea®) (328 KB) Rote-Hand-Brief 07/2013
Iclusig® (Ponatinib) (141 KB) Rote-Hand-Brief 04/2016
Idelalisib® (Zydelig) (189 KB) Rote-Hand-Brief 08/2016
Idelalisib (Zydelig®) (253 KB) Rote-Hand-Brief 03/2016
Imatinib (Glivec®) (141 KB) Rote-Hand-Brief 04/2016
Imbruvica® (Ibrutinib) (169 KB) Rote-Hand-Brief 07/2017
Immuntherapeutika bei MS (424 KB) Wirkstoff AKTUELL 12/2015
Imnovid® (Pomalidomid) (308 KB) Rote-Hand-Brief 04/2016
Imnovid® (Pomalidomid) (593 KB) Rote-Hand-Brief 08/2013
Imnovid® (Pomalidomid) (262 KB) Rote-Hand-Brief 04/2015
Impfstoffe, undichte Spritzen (137 KB) Rote-Hand-Brief 04/2018
ImplanonNXT® (Etonorgestrel) (0,9 MB) Rote-Hand-Brief 06/2016
Incivo® (Telaprevir) (352 KB) Rote-Hand-Brief 04/2013
Inclusig® (Ponatinib) (76 KB) Rote-Hand-Brief 11/2013
Inegy® (Ezetimib) (29 KB) KVSM 07/2010
Inegy® (Simvastatin/Ezetimib) (329 KB) Wirkstoff AKTUELL 11/2015
Infanrix® hexa (282 KB) Rote-Hand-Brief 10/2012
Infanrix® IPV+ Hib (263 KB) Rote-Hand-Brief 10/2012
Influenza-Lebendimpfstoff (Fluenz®) (57 KB) KVSM 03/2012
Informationen der Pharmaindustrie (37 KB) KVSM 07/2012
Insulinglulisin (Apidra®) (74 KB) Rote-Hand-Brief 09/2011
Intraartikuläre Injektion (33 KB) KVSM 01/2013
Intrauterinpessare (328 KB) Rote-Hand-Brief 07/2015
Intuniv® (Guanfacin) (326 KB) Wirkstoff AKTUELL 04/2016
Invega® (Paliperidon) (384 KB) Rote-Hand-Brief 09/2013
Invirase® (Saquinavir) (1,8 MB) Rote-Hand-Brief 07/2010
Invirase® (Saquinavir) (73 KB) Rote-Hand-Brief 05/2014
Iopromid (Ultravist® 300) (337 KB) Rote-Hand-Brief 11/2012
Ipratropium/Fenoterol (Berodual®) (26 KB) KVSM 06/2013
Ivabradin (Procoralan®) (0,9 MB) Wirkstoff AKTUELL 10/2013
Ivabradin (Procoralan®) (174 KB) Rote-Hand-Brief 12/2014
Ivabradin (Procoralan®) (88 KB) Rote-Hand-Brief 06/2014
Ivermectin (Solaantra®) (274 KB) Wirkstoff AKTUELL 11/2016

nach oben

J

Janumet® (Sitagliptin) (327 KB) Wirkstoff AKTUELL 05/2018
Januvia® (Sitagliptin) (327 KB) Wirkstoff AKTUELL 05/2018
Johanniskraut-Extrakt, Verordnungsfähigkeit (36 KB) KVSM 01/2010
Juluca® (Dolutegravir/Rilpivirin) (201 KB) Rote-Hand-Brief 06/2018

nach oben

K

Katadolon® (Flupirtin) (104 KB) Rote-Hand-Brief 07/2013
Kepivance® (Palifermin) (1,4 MB) Rote-Hand-Brief 04/2010
Ketoconazol (Nizoral®) (75 KB) Rote-Hand-Brief 08/2013
Ketoconazol (328 KB) Rote-Hand-Brief 03/2015
Ketoprofen (2,2 MB) Rote-Hand-Brief 08/2010
Keytruda® (Pembrolizumab) (220 KB) Rote-Hand-Brief 07/2018
Kontrazeptiva (1,6 MB) Rote-Hand-Brief 01/2019
Kontrazeptiva (6,2 MB) Rote-Hand-Brief 01/2014
Kortisonhaltige Nasensprays, Patienteninformation (50 KB) KBV 02/2017

nach oben

L

Lacosamid (Vimpat®) (31 KB) Rote-Hand-Brief 07/2011
Lacosamid (Vimpat®) (143 KB) Wirkstoff AKTUELL 11/2014
Lactobacillus rhamnosus GG-haltige Arzneimittel (39 KB) KVSonline 11/2017
Laif® 900 (34 KB) KVSM 12/2012
Lariam® (Mefloquin) (2,1 MB) Rote-Hand-Brief 08/2013
Ledipasvir (Harvoni®) (134 KB) Rote-Hand-Brief 05/2015
Leflunomid medac® (1,1 MB) Rote-Hand-Brief 10/2010
Lenalidomid (Revlimid®) (484 KB) Rote-Hand-Brief 10/2011
Lenalidomid (Revlimid®) (94 KB) Rote-Hand-Brief 12/2012
Lenalidomid (Revlimid®) (340 KB) Rote-Hand-Brief 11/2016
Lenalidomid (Revlimid®) (362 KB) Rote-Hand-Brief 04/2011
Lenalidomid (Revlimid®) (1,4 MB) Rote-Hand-Brief 12/2010
Lenalidomid (Revlimid®) (260 KB) Rote-Hand-Brief 06/2013
Lenograstim (Granocyte®) (243 KB) Rote-Hand-Brief 03/2014
Lepirudin (Refludan®) (255 KB) Rote-Hand-Brief 01/2010
Leuprorelin (Eligard®) (189 KB) Rote-Hand-Brief 12/2017
Leustatin® (Cladribin) (72 KB) Rote-Hand-Brief 12/2017
Levact® (Bendamustin) (291 KB) Rote-Hand-Brief 08/2017
Levofloxacin (Tavanic®) (589 KB) Rote-Hand-Brief 09/2012
Levothyroxin (Euthyrox®) (1,2 MB) Rote-Hand-Brief 04/2019
Linoladiol® N (72 KB) KVSonline 07/2013
Liraglutid (Victoza®) (379 KB) Wirkstoff AKTUELL 01/2018
Lisdexamfetamin (Elvanse®) (306 KB) Wirkstoff AKTUELL 10/2015
Litak® (Cladribin) (72 KB) Rote-Hand-Brief 12/2017
Lucentis® (Ranibizumab) (75 KB) Rote-Hand-Brief 02/2011
Lynparza® (Olaparib) (191 KB) Rote-Hand-Brief 05/2018

nach oben

M

MabThera® (Rituximab) (2,0 MB) Rote-Hand-Brief 08/2011
MabThera® (Rituximab) (54 KB) Rote-Hand-Brief 11/2013
MabThera® (Rituximab) (1,9 MB) Rote-Hand-Brief 04/2013
Maxipime® (Cefepim) (85 KB) Rote-Hand-Brief 06/2018
Medikinet® adult (Methylphenidat) (33 KB) KVSM 09/2011
Mefloquin (Lariam®) (2,1 MB) Rote-Hand-Brief 08/2013
Methadon, Patienteninformation (62 KB) KBV 10/2017
Methocarbamol (Ortoton®) (372 KB) Wirkstoff AKTUELL 05/2015
Methoxsalen (Uvadex™) (57 KB) Rote-Hand-Brief 12/2011
Methylphenidat (Medikinet® adult) (33 KB) KVSM 09/2011
Metoclopramid, Verkehrsfähigkeit (69 KB) KVSonline 04/2014
Midazolam (Buccolam®) (113 KB) Rote-Hand-Brief 11/2017
Midazolam (Buccolam®) (103 KB) Rote-Hand-Brief 01/2018
Mimpara® (Cinacalcet) (222 KB) Rote-Hand-Brief 03/2013
Mirabegron (Betmiga®) (259 KB) Rote-Hand-Brief 09/2015
Mirabegron (Betmiga®) (300 KB) Wirkstoff AKTUELL 11/2017
Misodel® (Misoprostol) (107 KB) Rote-Hand-Brief 11/2017
Mistelpräparate (34 KB) KVSM 09/2012
Modafinil (Vigil®) (97 KB) Rote-Hand-Brief 02/2011
Mucosolvan® (Ambroxol) (87 KB) Rote-Hand-Brief 08/2013
Multaq® (Dronedaron) (424 KB) Rote-Hand-Brief 06/2011
Multaq® (Dronedaron) (790 KB) Wirkstoff AKTUELL 09/2012
Multaq® (Dronedaron) (161 KB) Rote-Hand-Brief 01/2011
Multimedikation (30 KB) KVSM 09/2014
Muskelrelaxantien (39 KB) KVSM 12/2013
Mycophenolat (CellCept®) (55 KB) Rote-Hand-Brief 12/2014
Mycophenolat (Myfortic®) (93 KB) Rote-Hand-Brief 02/2016
Mycophenolat (82 KB) Rote-Hand-Brief 02/2018
Mycophenolatmofetil (Cellcept®) (367 KB) Rote-Hand-Brief 11/2015
Myfortic® (Mycophenolat) (93 KB) Rote-Hand-Brief 02/2016

nach oben

N

Nalmefen (Selincro®) (350 KB) Wirkstoff AKTUELL 10/2015
Natalizumab (Tysabri®) (1,4 MB) Rote-Hand-Brief 02/2010
Natalizumab (Tysabri®) (331 KB) Rote-Hand-Brief 03/2016
Natriumoxybat (Xyrem®) (1,1 MB) Rote-Hand-Brief 08/2010
Neue orale Antikoagulantien, Wirtschaftlichkeit (55 KB) KVSM 11/2013
Neulasta® (Pegfilgrastim) (313 KB) Rote-Hand-Brief 08/2013
Neupogen® (Filgrastim) (313 KB) Rote-Hand-Brief 08/2013
Nikotinsäure/Laropiprant (Tredaptive®) (1,7 MB) Rote-Hand-Brief 12/2012
Nikotinsäure/Laropiprant (Tredaptive®) (1,5 MB) Rote-Hand-Brief 01/2013
Nilotinib (Tasigna®) (141 KB) Rote-Hand-Brief 04/2016
Nipruss (0,9 MB) Rote-Hand-Brief 05/2013
Nitrate (34 KB) KVSM 09/2011
Nizoral® (Ketoconazol) (75 KB) Rote-Hand-Brief 08/2013
NOAK (Direkte orale Antikoagulanzien) (337 KB) Wirkstoff AKTUELL 10/2017
Norgestimat (Cilest®, Pramino®) (337 KB) Rote-Hand-Brief 06/2013
Noxafil® (Posaconazol) (758 KB) Rote-Hand-Brief 07/2016
Nplate® (Romiplostim) (365 KB) Rote-Hand-Brief 09/2011
Nplate® (Romiplostim) (1,6 MB) Rote-Hand-Brief 12/2010
Numeta G16 (90 KB) Rote-Hand-Brief 10/2013
Numeta G13 (117 KB) Rote-Hand-Brief 06/2013
Nutrineal® (Peritonealdialyse-Lösung) (41 KB) Rote-Hand-Brief 01/2011

nach oben

O

Obeticholsäure (Ocaliva®) (92 KB) Rote-Hand-Brief 02/2018
Ocaliva® (Obeticholsäure) (92 KB) Rote-Hand-Brief 02/2018
Octenisept® (Octenidindihydrochlorid, Phenoxyethanol) (2,4 MB) Rote-Hand-Brief 01/2011
Odomzo® (Sonidegib) (46 KB) Rote-Hand-Brief 01/2018
Ofatumumab (Arzerra®) (1,0 MB) Rote-Hand-Brief 12/2013
Ofatumumab (Arzerra®) (270 KB) Rote-Hand-Brief 07/2014
Olaparib (Lynparza®) (191 KB) Rote-Hand-Brief 05/2018
Ondansetron (Zofran®) (548 KB) Rote-Hand-Brief 07/2013
Ortoton® (Methocarbamol) (372 KB) Wirkstoff AKTUELL 05/2015
Otezla® (Apremilast) (346 KB) Rote-Hand-Brief 11/2016
Otezla® (Apremilast) (308 KB) Wirkstoff AKTUELL 09/2016
Oxycodon/Naloxon (Targin®) (1,1 MB) Wirkstoff AKTUELL 11/2012

nach oben

P

Paclitaxel (Abraxane®) (236 KB) Rote-Hand-Brief 01/2014
Palexia® (Tapentadol) (876 KB) Wirkstoff AKTUELL 06/2012
Palexia® (Tapentadol) (303 KB) Wirkstoff AKTUELL 08/2018
Palifermin (Kepivance®) (1,4 MB) Rote-Hand-Brief 04/2010
Paliperidon (Invega®, Xeplion®) (384 KB) Rote-Hand-Brief 09/2013
Panitumumab (Vectibix®) (546 KB) Rote-Hand-Brief 08/2013
Panitumumab (Vectibix®) (225 KB) Rote-Hand-Brief 04/2010
Panitumumab (Vectibix®) (1,5 MB) Rote-Hand-Brief 11/2011
Panitumumab (Vectibix®) (203 KB) Rote-Hand-Brief 05/2011
Panitumumab (Vectibix®) (439 KB) Rote-Hand-Brief 07/2012
Paracetamol i.v. (Perfalgan®) (1,2 MB) Rote-Hand-Brief 07/2010
Paracetamol i.v. (Perfalgan®) (281 KB) Rote-Hand-Brief 03/2012
Partusisten® (Fenoterol) (819 KB) Rote-Hand-Brief 09/2013
Partusisten® intrapartal (Fenoterol) (106 KB) Rote-Hand-Brief 10/2012
Pazopanib (Votrient®) (156 KB) Rote-Hand-Brief 07/2013
Pedea® (Ibuprofen) (328 KB) Rote-Hand-Brief 07/2013
Pegfilgrastim (Neulasta®) (313 KB) Rote-Hand-Brief 08/2013
Pembrolizumab (Keytruda®) (220 KB) Rote-Hand-Brief 07/2018
Perfalgan® (Paracetamol i.v.) (1,2 MB) Rote-Hand-Brief 07/2010
Perfalgan® (Paracetamol i.v.) (281 KB) Rote-Hand-Brief 03/2012
Peritonealdialyse-Lösungen (Dianeal®, Extraneal®, Nutrineal®) (41 KB) Rote-Hand-Brief 01/2011
Peritonealdialyse-Lösungen (74 KB) Rote-Hand-Brief 01/2011
Piritramid-hameln® (404 KB) Rote-Hand-Brief 07/2012
Pletal® (Cilostazol) (3,0 MB) Rote-Hand-Brief 05/2013
Pletal® (Cilostazol) (35 KB) KVSM 02/2012
Pletal® (Cilostazol) (43 KB) KVSonline 05/2015
Pneumokokken-Schutzimpfung (56 KB) KVSonline 03/2013
Pomalidomid (Imnovid®) (593 KB) Rote-Hand-Brief 08/2013
Pomalidomid (Imnovid®) (308 KB) Rote-Hand-Brief 04/2016
Pomalidomid (Imnovid®) (262 KB) Rote-Hand-Brief 04/2015
Ponatinib (Iclusig®) (141 KB) Rote-Hand-Brief 04/2016
Ponatinib (Inclusig®) (76 KB) Rote-Hand-Brief 11/2013
Posaconazol (Noxafil®) (758 KB) Rote-Hand-Brief 07/2016
Pradaxa® (Dabigatranetexilat) (108 KB) Rote-Hand-Brief 09/2013
Pradaxa® (Dabigatranetexilat) (172 KB) Wirkstoff AKTUELL 10/2009
Pradaxa® (Dabigatranetexilat) (338 KB) Rote-Hand-Brief 01/2013
Pradaxa® (Dabigatranetexilat) (1,0 MB) Wirkstoff AKTUELL 01/2013
Pradaxa® (Dabigatranetexilat) (486 KB) Rote-Hand-Brief 10/2011
Praluent® (Alirocumab) (47 KB) KVSonline 10/2016
Pramino® (Norgestimat) (337 KB) Rote-Hand-Brief 06/2013
Prasugrel (Efient®) (126 KB) KVSM 12/2010
Prasugrel (Efient®) (410 KB) Rote-Hand-Brief 12/2013
Pregabalin (43 KB) KVSM 02/2015
Prezista® (Darunavir/Cobicistat) (395 KB) Rote-Hand-Brief 06/2018
Procoralan® (Ivabradin) (88 KB) Rote-Hand-Brief 06/2014
Procoralan® (Ivabradin) (0,9 MB) Wirkstoff AKTUELL 10/2013
Procoralan® (Ivabradin) (174 KB) Rote-Hand-Brief 12/2014
Prolia® (Denosumab) (262 KB) Rote-Hand-Brief 09/2014
Prolia® (Denosumab) (339 KB) Wirkstoff AKTUELL 10/2018
Prolia® (Denosumab) (403 KB) Rote-Hand-Brief 02/2013
Prolia® (Denosumab) (185 KB) Wirkstoff AKTUELL 01/2011
Protelos® (Strontiumranelat) (218 KB) Rote-Hand-Brief 03/2014
Protelos® (Strontiumranelat) (1,7 MB) Rote-Hand-Brief 04/2012
Protelos® (Strontiumranelat) (217 KB) Rote-Hand-Brief 05/2013
Protonenpumpeninhibitoren, Selbstmedikation (35 KB) KVSM 01/2010
Protonenpumpeninhibitoren (335 KB) KVSM 09/2018
Strontiumranelat (Protelos®) (218 KB) Rote-Hand-Brief 03/2014

nach oben

Q

Qutenza® (Capsaicin) (249 KB) Wirkstoff AKTUELL 08/2010

nach oben

R

Rabattverträge, aut-idem-Kreuz (35 KB) KVSM 12/2012
Radium-223-dichlorid (Xofigo®) (77 KB) Rote-Hand-Brief 03/2018
Raloxifen (120 KB) Wirkstoff AKTUELL 07/2014
Ranexa® (Ranolazin) (230 KB) Wirkstoff AKTUELL 12/2010
Ranibizumab (Lucentis®) (75 KB) Rote-Hand-Brief 02/2011
Ranolazin (Ranexa®) (230 KB) Wirkstoff AKTUELL 12/2010
Rapiscan® (Regadenoson) (86 KB) Rote-Hand-Brief 12/2014
Rasagilin (Azilect®) (550 KB) Wirkstoff AKTUELL 07/2013
Rasilez® (Aliskiren) (45 KB) KVSM 09/2010
Reboxetin (Solvex®, Edronax®) (31 KB) KVSM 06/2011
Redibag® (HES) (116 KB) Rote-Hand-Brief 07/2013
Reductil® (Sibutramin) (326 KB) Rote-Hand-Brief 01/2010
Refludan® (Lepirudin) (255 KB) Rote-Hand-Brief 01/2010
Regadenoson (Rapiscan®) (86 KB) Rote-Hand-Brief 12/2014
Regranex® (Becaplermin) (60 KB) Rote-Hand-Brief 03/2010
Reminyl® (Galantaminhydrobromid) (133 KB) Rote-Hand-Brief 09/2015
Repatha® (Evolocumab) (48 KB) KVSonline 08/2016
Retigabin (Trobalt®) (343 KB) Rote-Hand-Brief 06/2013
Revatio® (Sildenafil) (183 KB) Rote-Hand-Brief 10/2018
Revatio® (Sildenafil) (225 KB) Rote-Hand-Brief 10/2011
Revlimid® (Lenalidomid) (94 KB) Rote-Hand-Brief 12/2012
Revlimid® (Lenalidomid) (362 KB) Rote-Hand-Brief 04/2011
Revlimid® (Lenalidomid) (1,4 MB) Rote-Hand-Brief 12/2010
Revlimid® (Lenalidomid) (340 KB) Rote-Hand-Brief 11/2016
Revlimid® (Lenalidomid) (484 KB) Rote-Hand-Brief 10/2011
Revlimid® (Lenalidomid) (260 KB) Rote-Hand-Brief 06/2013
Rhesonativ® (Anti-D-Immunglobulin) (4,7 MB) Rote-Hand-Brief 10/2013
Ribavirin (Virazole®) (91 KB) Rote-Hand-Brief 12/2011
Riociguat (Adempas®) (186 KB) Rote-Hand-Brief 07/2016
Risperdal® (Risperidon) (384 KB) Rote-Hand-Brief 09/2013
Rituximab (MabThera®) (54 KB) Rote-Hand-Brief 11/2013
Rituximab (MabThera®) (1,9 MB) Rote-Hand-Brief 04/2013
Rituximab (MabThera®) (2,0 MB) Rote-Hand-Brief 08/2011
Rivaroxaban (Xarelto®) bei Vorhofflimmern (1,0 MB) Wirkstoff AKTUELL 03/2013
Rivaroxaban (Xarelto®) (108 KB) Rote-Hand-Brief 09/2013
Rivaroxaban (Xarelto®) (163 KB) Rote-Hand-Brief 10/2018
Rivaroxaban (Xarelto®) (174 KB) Wirkstoff AKTUELL 12/2009
Rivastigmin (Exelon®) (74 KB) Wirkstoff AKTUELL 01/2010
RoActemra® (Tocilizumab) (1,7 MB) Rote-Hand-Brief 12/2010
Roflumilast (Daxas®) (212 KB) Wirkstoff AKTUELL 06/2011
Romiplostim (Nplate®) (1,6 MB) Rote-Hand-Brief 12/2010
Romiplostim (Nplate®) (365 KB) Rote-Hand-Brief 09/2011
Rosiglitazon (237 KB) Rote-Hand-Brief 09/2010

nach oben

S

Saccharomyces boulardii (77 KB) Rote-Hand-Brief 01/2018
Safinamid (Xadago®) (316 KB) Wirkstoff AKTUELL 08/2016
Samsca® (Tolvaptan) (569 KB) Rote-Hand-Brief 03/2012
Samsca® (Tolvaptan) (165 KB) Rote-Hand-Brief 05/2013
Saquinavir (Invirase®) (73 KB) Rote-Hand-Brief 05/2014
Saquinavir (Invirase®) (1,8 MB) Rote-Hand-Brief 07/2010
Schmerzmittel, Anwendungseinschränkungen (46 KB) KVSM 01/2014
Schmerzmittel, Anwendungseinschränkungen (60 KB) KVSonline 08/2013
Schwefelhexafluorid (SonoVue®) (457 KB) Rote-Hand-Brief 12/2014
Seebri® Breezhaler® (Glycopyrronium) (128 KB) Wirkstoff AKTUELL 03/2014
Selexipag (Uptravi®) (113 KB) Rote-Hand-Brief 06/2017
Selincro® (Nalmefen) (350 KB) Wirkstoff AKTUELL 10/2015
SGLT2-Inhibitoren (0,9 MB) Rote-Hand-Brief 01/2019
Sibutramin (Reductil®) (326 KB) Rote-Hand-Brief 01/2010
Sildenafil (Revatio®, Viagra®) (183 KB) Rote-Hand-Brief 10/2018
Sildenafil (Revatio®) (225 KB) Rote-Hand-Brief 10/2011
Silodosin (Urorec®) (224 KB) Wirkstoff AKTUELL 02/2011
Simulect® (Basiliximab) (334 KB) Rote-Hand-Brief 09/2014
Simvastatin/Ezetimib (Inegy®, Goltor®) (329 KB) Wirkstoff AKTUELL 11/2015
Sitagliptin (Januvia®, Janumet®, Velmetia®, Xelevia®) (327 KB) Wirkstoff AKTUELL 05/2018
Sitaxentan (Thelin®) (130 KB) Rote-Hand-Brief 12/2010
Sofosbuvir (Sovaldi®, Harvoni®) (134 KB) Rote-Hand-Brief 05/2015
Solaantra® (Ivermectin) (274 KB) Wirkstoff AKTUELL 11/2016
Solvex® (Reboxetin) (31 KB) KVSM 06/2011
Sonidegib (Odomzo®) (46 KB) Rote-Hand-Brief 01/2018
SonoVue® (Schwefelhexafluorid) (457 KB) Rote-Hand-Brief 12/2014
Sovaldi® (Sofosbuvir) (134 KB) Rote-Hand-Brief 05/2015
Sprycel® (Dasatinib) (344 KB) Rote-Hand-Brief 08/2011
Sprycel® (Dasatinib) (141 KB) Rote-Hand-Brief 04/2016
Stavudin (Zerit®) (1,5 MB) Rote-Hand-Brief 03/2011
Stückelungsregelung (30 KB) KVSM 03/2011
Stückzahlen, Abgaberegelungen (36 KB) KVSM 12/2012
Stelara® (Ustekinumab) (887 KB) Wirkstoff AKTUELL 01/2014
Stelara® (Ustekinumab) (180 KB) Rote-Hand-Brief 11/2014
Strattera® (Atomoxetin) (571 KB) Rote-Hand-Brief 12/2011
Stribild® (Elvitegravir/Cobicistat/Emtricitabin/Tenofovirdisoproxil) (789 KB) Rote-Hand-Brief 03/2019
Strontiumranelat (Protelos®) (1,7 MB) Rote-Hand-Brief 04/2012
Strontiumranelat (Protelos®) (217 KB) Rote-Hand-Brief 05/2013
Substitutions-Ausschluss (67 KB) KVSonline 01/2015
Substitutionsregeln in der Arzneimittelverordnung (32 KB) KVSM 05/2012
Sunitinib (Sutent®) (1,4 MB) Rote-Hand-Brief 11/2010
Supertendin® (Dexamethason) (248 KB) Rote-Hand-Brief 10/2011
Supertendin® (Dexamethason) (200 KB) Rote-Hand-Brief 11/2011
Sutent® (Sunitinib) (1,4 MB) Rote-Hand-Brief 11/2010
Sycrest® (Asenapin) (866 KB) Wirkstoff AKTUELL 11/2013
Symtuza® (Darunavir/Cobicistat) (395 KB) Rote-Hand-Brief 06/2018

nach oben

T

Tapentadol (Palexia®) (876 KB) Wirkstoff AKTUELL 06/2012
Tapentadol (Palexia®) (303 KB) Wirkstoff AKTUELL 08/2018
Tarceva® (Erlotinib) (623 KB) Rote-Hand-Brief 01/2016
Targin® (Oxycodon/Naloxon) (1,1 MB) Wirkstoff AKTUELL 11/2012
Tasigna® (Nilotinib) (141 KB) Rote-Hand-Brief 04/2016
Tavanic® (Levofloxacin) (589 KB) Rote-Hand-Brief 09/2012
Tecentriq® (Atezolizumab) (364 KB) Rote-Hand-Brief 07/2018
Tecfidera® (Dimethylfumarat ) (442 KB) Rote-Hand-Brief 11/2015
Tecfidera® (Dimethylfumarat) (89 KB) Rote-Hand-Brief 12/2014
Telaprevir (Incivo®) (352 KB) Rote-Hand-Brief 04/2013
Telavancin (Vibativ®) (89 KB) Rote-Hand-Brief 01/2015
Temozolomid Hexal® (Temozolomid ) (307 KB) Rote-Hand-Brief 07/2010
Temozolomid Hospira® (Temozolomid ) (146 KB) Rote-Hand-Brief 07/2010
Temozolomid (142 KB) Rote-Hand-Brief 12/2013
Temsirolimus (Torisel®) (395 KB) Rote-Hand-Brief 12/2011
Teriparatid (Forsteo®) (315 KB) Wirkstoff AKTUELL 11/2018
Tetrazepam (331 KB) Rote-Hand-Brief 06/2013
Thalidomid (358 KB) Rote-Hand-Brief 11/2015
Thalidomide Celgene™ (370 KB) Rote-Hand-Brief 04/2013
Thalidomide Celgene™ (318 KB) Rote-Hand-Brief 06/2016
Thalidomide Celgene™ (124 KB) Rote-Hand-Brief 04/2011
Thelin® (Sitaxentan) (130 KB) Rote-Hand-Brief 12/2010
Thiamazol (1,5 MB) Rote-Hand-Brief 02/2019
Thromboseprophylaxe, medikamentöse (39 KB) KVSM 10/2010
Ticagrelor (Brilique®) (36 KB) KVSM 09/2012
Tigecyclin (Tygacil®) (113 KB) Rote-Hand-Brief 03/2011
Tilidin, BtM-Pflicht (32 KB) KVSM 11/2012
Timolol/Dorzolamid (Cosopt®) (163 KB) Rote-Hand-Brief 11/2013
Tivicay® (Dolutegravir) (201 KB) Rote-Hand-Brief 06/2018
TNF-alpha-Hemmer (25 KB) KVSM 09/2014
Tocilizumab (RoActemra®) (1,7 MB) Rote-Hand-Brief 12/2010
Tofacitinib (Xeljanz®) (0,9 MB) Rote-Hand-Brief 03/2019
Tolperison (101 KB) Rote-Hand-Brief 02/2013
Tolvaptan (Samsca®) (569 KB) Rote-Hand-Brief 03/2012
Tolvaptan (Samsca®) (165 KB) Rote-Hand-Brief 05/2013
Torisel® (Temsirolimus) (395 KB) Rote-Hand-Brief 12/2011
Trancolong® (Flupirtin) (104 KB) Rote-Hand-Brief 07/2013
Trancopal® (Flupirtin) (104 KB) Rote-Hand-Brief 07/2013
Trastuzumab (Herceptin®) (371 KB) Rote-Hand-Brief 04/2014
Trastuzumab (Herceptin®) (102 KB) Rote-Hand-Brief 03/2017
Tredaptive® (Nikotinsäure/Laropiprant) (1,7 MB) Rote-Hand-Brief 12/2012
Tredaptive® (Nikotinsäure/Laropiprant) (1,5 MB) Rote-Hand-Brief 01/2013
Triamcinolon (43 KB) KVSM 02/2015
Trimbow® (Beclometason/Formoterol/Glycopyrronium) (276 KB) Wirkstoff AKTUELL 08/2017
Triumeq® (Dolutegravir/Abacavir/Lamivudin) (201 KB) Rote-Hand-Brief 06/2018
Trobalt® (Retigabin) (343 KB) Rote-Hand-Brief 06/2013
Tybost® (Cobicistat) (789 KB) Rote-Hand-Brief 03/2019
Tygacil® (Tigecyclin) (113 KB) Rote-Hand-Brief 03/2011
Typhim Vi® (Typhus-Polysaccharid-Impfstoff) (179 KB) Rote-Hand-Brief 09/2012
Tysabri® (Natalizumab) (1,4 MB) Rote-Hand-Brief 02/2010
Tysabri® (Natalizumab) (331 KB) Rote-Hand-Brief 03/2016

nach oben

U

Ulipristalacetat (Esmya®) (428 KB) Rote-Hand-Brief 07/2018
Ulipristalacetat (Esmya®) (142 KB) Rote-Hand-Brief 02/2018
Ultibro® Breezhaler® (Glycopyrronium) (128 KB) Wirkstoff AKTUELL 03/2014
Ultravist® 300 (Iopromid) (337 KB) Rote-Hand-Brief 11/2012
Ultreon® (Azithromycin) (202 KB) Rote-Hand-Brief 05/2018
Umeclidinium/Vilanterol (Anoro®) (301 KB) Wirkstoff AKTUELL 08/2015
Uptravi® (Selexipag) (113 KB) Rote-Hand-Brief 06/2017
Urologische Spasmolytika (0,9 MB) Wirkstoff AKTUELL 07/2013
Urorec® (Silodosin) (224 KB) Wirkstoff AKTUELL 02/2011
Ustekinumab (Stelara®) (180 KB) Rote-Hand-Brief 11/2014
Ustekinumab (Stelara®) (887 KB) Wirkstoff AKTUELL 01/2014
Uvadex™ (Methoxsalen) (57 KB) Rote-Hand-Brief 12/2011

nach oben

V

Valdoxan® (Agomelatin) (164 KB) Wirkstoff AKTUELL 04/2010
Valproat (6,4 MB) Rote-Hand-Brief 12/2014
Valproat (4,1 MB) Rote-Hand-Brief 11/2018
Vectibix® (Panitumumab) (546 KB) Rote-Hand-Brief 08/2013
Vectibix® (Panitumumab) (1,5 MB) Rote-Hand-Brief 11/2011
Vectibix® (Panitumumab) (203 KB) Rote-Hand-Brief 05/2011
Vectibix® (Panitumumab) (439 KB) Rote-Hand-Brief 07/2012
Vectibix® (Panitumumab) (225 KB) Rote-Hand-Brief 04/2010
Vedolizumab (Entyvio®) (379 KB) Wirkstoff AKTUELL 10/2016
Velcade® (Bortezomib) (118 KB) Rote-Hand-Brief 01/2012
Velmetia® (Sitagliptin) (327 KB) Wirkstoff AKTUELL 05/2018
Vemurafenib (Zelboraf®) (121 KB) Rote-Hand-Brief 08/2013
Vemurafenib (Zelboraf®) (272 KB) Rote-Hand-Brief 10/2015
Verbandstoffe, Verordnungsfähigkeit (30 KB) KVSM 11/2014
Verbandstoff-Liste (124 KB) KVSM 07/2018
Verordnungsfähigkeit nach AM-RL (459 KB) KBV 06/2018
Verordnungsfähigkeit nach AM-RL (307 KB) KBV 04/2014
Viagra® (Sildenafil) (183 KB) Rote-Hand-Brief 10/2018
Vibativ® (Telavancin) (89 KB) Rote-Hand-Brief 01/2015
Victoza® (Liraglutid) (379 KB) Wirkstoff AKTUELL 01/2018
Victrelis® (Boceprevir) (117 KB) Rote-Hand-Brief 02/2012
Viekirax® (Ombitasvir, Paritaprevir, Ritonavir) (344 KB) Rote-Hand-Brief 01/2016
Vigil® (Modafinil) (97 KB) Rote-Hand-Brief 02/2011
Vilanterol/Umeclidinium (Anoro®) (301 KB) Wirkstoff AKTUELL 08/2015
Vimpat® (Lacosamid) (31 KB) Rote-Hand-Brief 07/2011
Vimpat® (Lacosamid) (143 KB) Wirkstoff AKTUELL 11/2014
Virazole® (Ribavirin) (91 KB) Rote-Hand-Brief 12/2011
Vismodegib (Erivedge®) (49 KB) Rote-Hand-Brief 06/2016
Vismodegib (Erivedge®) (2,8 MB) Rote-Hand-Brief 07/2013
Vistide® (Cidofovir) (122 KB) Rote-Hand-Brief 01/2011
Vistide® (Cidofovir) (93 KB) Rote-Hand-Brief 02/2013
Vitamin D-Monopräparate (83 KB) KVSonline 04/2013
Vivaglobin® (humanes Immunglobulin) (352 KB) Rote-Hand-Brief 03/2011
Volibris® (Ambrisentan) (0,9 MB) Rote-Hand-Brief 06/2012
Votrient® (Pazopanib) (156 KB) Rote-Hand-Brief 07/2013

nach oben

X

Xadago® (Safinamid) (316 KB) Wirkstoff AKTUELL 08/2016
Xagrid® (Anagrelid) (505 KB) Rote-Hand-Brief 01/2013
Xalkori® (Crizotinib) (137 KB) Rote-Hand-Brief 10/2015
Xarelto® (Rivaroxaban) bei Vorhofflimmern (1,0 MB) Wirkstoff AKTUELL 03/2013
Xarelto® (Rivaroxaban) (163 KB) Rote-Hand-Brief 10/2018
Xarelto® (Rivaroxaban) (108 KB) Rote-Hand-Brief 09/2013
Xarelto® (Rivaroxaban) (174 KB) Wirkstoff AKTUELL 12/2009
Xelevia® (Sitagliptin) (327 KB) Wirkstoff AKTUELL 05/2018
Xeljanz® (Tofacitinib) (0,9 MB) Rote-Hand-Brief 03/2019
Xeloda® (Capecitabin) (82 KB) Rote-Hand-Brief 12/2013
Xeplion® (Paliperidon) (384 KB) Rote-Hand-Brief 09/2013
Xgeva® (Denosumab) (274 KB) Rote-Hand-Brief 09/2014
Xgeva® (Denosumab) (166 KB) Rote-Hand-Brief 07/2015
Xgeva® (Denosumab) (416 KB) Rote-Hand-Brief 09/2012
Xigris® (Drotrecogin alfa) (209 KB) Rote-Hand-Brief 10/2011
Xofigo® (Radium-223-dichlorid) (77 KB) Rote-Hand-Brief 03/2018
Xyrem® (Natriumoxybat) (1,1 MB) Rote-Hand-Brief 08/2010

nach oben

Z

Zebinix® (Eslicarbazepinacetat) (794 KB) Wirkstoff AKTUELL 11/2012
Zelboraf® (Vemurafenib) (121 KB) Rote-Hand-Brief 08/2013
Zelboraf® (Vemurafenib) (272 KB) Rote-Hand-Brief 10/2015
Zerit® (Stavudin) (1,5 MB) Rote-Hand-Brief 03/2011
Zinbryta® (Daclizumab) (264 KB) Rote-Hand-Brief 11/2017
Zinbryta® (Daclizumab) (457 KB) Rote-Hand-Brief 07/2017
Zinbryta® (Daclizumab) (277 KB) Rote-Hand-Brief 08/2018
Zinbryta® (Daclizumab) (261 KB) Rote-Hand-Brief 03/2018
Zithromax® (Azithromycin) (202 KB) Rote-Hand-Brief 05/2018
Zofran® (Ondansetron) (548 KB) Rote-Hand-Brief 07/2013
Zostex® (Brivudin) (440 KB) Rote-Hand-Brief 08/2012
Zydelig® (Idelalisib) (253 KB) Rote-Hand-Brief 03/2016
Zydelig (Idelalisib®) (189 KB) Rote-Hand-Brief 08/2016

nach oben